KGP-25
Product Specifications
Target
Sodium Channel, GABA Receptor
Related Pathways
Membrane transporter/Ion channel, Neuroscience
Bioactivity
KGP-25 is an inhibitor of the voltage-gated sodium channel 1.8 (Nav1.8), utilized for analgesia by targeting the peripheral nervous system (PNS) . Additionally, it targets the γ-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for use as a general anesthetic.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6208572-01 0.1 mL
SMAD3 (SMAD Family Member 3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396) (MaxLight 490)
Sign In for Pricing
View Details MBS6208572-02 5x 0.1 mL
SMAD3 (SMAD Family Member 3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396) (MaxLight 490)
Sign In for Pricing
View Details MBS1011233-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus subsp. cytotoxis Acetylglutamate kinase (argB)
Sign In for Pricing
View Details